NanoRepro AG (ETR:NN6)

Market Cap	19.87M
Revenue (ttm)	5.17M
Net Income (ttm)	-1.72M
Shares Out	12.61M
EPS (ttm)	-0.14
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	7,541
Average Volume	6,180
Open	1.500
Previous Close	1.500
Day's Range	1.460 - 1.530
52-Week Range	1.165 - 2.120
Beta	0.60
RSI	45.10
Earnings Date	Dec 22, 2025

About NanoRepro AG

NanoRepro AG engages in the development, manufacture, and distribution of rapid diagnostic tests and food supplements for home and professional use in Germany and internationally. The company provides products in the areas of family planning and disease detection, as well as food intolerances, allergies, and infectious diseases. It offers rapid diagnostic tests, such as family planning, and preventive healthcare line products. The company also develops and commercializes immunochromatographic lateral flow tests; and tests for hospitals and medi...

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 2006
• Employees: 23
• Stock Exchange: Deutsche Börse Xetra
• Ticker Symbol: NN6

Financial Performance

In 2024, NanoRepro AG's revenue was 4.51 million, an increase of 41.68% compared to the previous year's 3.18 million. Losses were -2.05 million, -56.34% less than in 2023.